DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS
  1. Home
  2. PCRP Research Highlights/News
  3. CDMRP Scientist Honored by the Prostate Cancer Foundation

NEWS RELEASE

Released: November 23, 2011

CDMRP Scientist Honored by the Prostate Cancer Foundation

Dr. Carolyn Best, Program Manager for the Department of Defense Congressionally Directed Medical Research Programs (CDMRP) Prostate Cancer Research Program (PCRP), was recently honored by the Prostate Cancer Foundation at their 18th Annual Scientific Retreat.

The PCF presented Dr. Best with an award for “Exemplary Public Service and Outstanding Leadership in Prostate Cancer Research.” Dr. Howard Soule, Chief Science Officer and Executive Vice President for the PCF, said the honor was well-deserved.

“The PCRP has been a very effective mechanism for discovery and development of new treatments for prostate cancer, and we are very pleased to recognize Carolyn’s leadership and commitment to this important public service,” said Dr. Soule. “Carolyn’s contributions to the field of prostate cancer research are greatly appreciated by PCF, the network of researchers, and patients and their families.”

Dr. Best has worked at the CDMRP since 2006, and has been program manager for the PCRP for four years. Formerly a research fellow of the National Cancer Institute, she worked as a cancer researcher for 14 years before joining the CDMRP. Dr. Best received her Ph.D. in pathology from the University of Maryland, Baltimore.

“I am truly humbled and grateful for this honor, and I share it with my colleagues at the CDMRP and all researchers working toward new discoveries to eliminate death and suffering from prostate cancer,” Dr. Best said. “This award is a testament to the partnerships that have been formed between prostate cancer advocates, physicians and scientists, and public and private funders of prostate cancer research, all of us working together toward the same goal.”

The PCRP was created in 1997, and has awarded more than 2,300 research grants worth more than $935 million. Awarding grants that span the research spectrum from initial exploration of new concepts and discoveries, further development of innovative ideas, and facilitating preclinical and clinical development of new approaches to prostate cancer treatment and management, the PCRP focuses on funding research that will have a major impact for prostate cancer patients. The PCRP also emphasizes health disparities, translational research, and encouraging the best new researchers to join the field.

Point of Contact:


The Congressionally Directed Medical Research Programs (CDMRP) funds innovative bio-medical competitive awards and manages research programs in cancer, military relevant injuries and conditions, and specific disease programs for the benefit of all Americans. Recognized for our unique collaborations with scientists, clinicians, consumers, and the military, the CDMRP is a subordinate command of the United States Army Medical Research and Materiel Command, Department of Defense (https://cdmrp.army.mil).